Epothilone D 1mg 1mg | Purity Not Available
Adooq Bioscience
Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
More Information Supplier PageEpothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
More Information Supplier PageDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
More Information Supplier PageDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
More Information Supplier PageDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
More Information Supplier PageDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
More Information Supplier PageDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively.
More Information Supplier PageMK-5108, also known as VX-689, is a competitive inhibitor of the ATP-binding site of aurora A kinase.
More Information Supplier PageMK-5108, also known as VX-689, is a competitive inhibitor of the ATP-binding site of aurora A kinase.
More Information Supplier PageMK-5108, also known as VX-689, is a competitive inhibitor of the ATP-binding site of aurora A kinase.
More Information Supplier PageAstragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier Page